Study to investigate the behaviour of paracetamol in the body of patients over 80 years old admitted to an acute geriatric ward
Phase 1
- Conditions
- PyrexiaPainTherapeutic area: Diseases [C] - Symptoms and general pathology [C23]
- Registration Number
- EUCTR2015-004217-24-BE
- Lead Sponsor
- Z Leuven
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
80 years or older
Admitted to acute geriatric ward of University Hospitals Leuven
Oral intake of Dafalgan (paracetamol) tablets, 3 times 1 gram per day for at least 4 intakes before inclusion
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 40
Exclusion Criteria
Downgrading of care in terms of palliative situation
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method